Osteoporosis and trace elements - An overview

被引:177
作者
Aaseth, Jan [1 ]
Boivin, Georges [2 ,3 ]
Andersen, Ole [4 ]
机构
[1] Innlandet Hosp Trust, Dept Med, N-2226 Kongsvinger, Norway
[2] Univ Med, INSERM, UMR 1033, F-69372 Lyon 08, France
[3] Univ Lyon, F-69008 Lyon, France
[4] Roskilde Univ, Dept Sci Syst & Models, DK-4000 Roskilde, Denmark
关键词
Osteoporosis; Trace elements; Mineral elements; Treatment; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; FLUORIDE; STRONTIUM; RESORPTION; FRACTURES; CALCIUM; SUPPLEMENTATION; ESTROGEN;
D O I
10.1016/j.jtemb.2012.03.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
More than 200 million people are affected by osteoporosis worldwide, as estimated by 2 million annual hip fractures and other debilitating bone fractures (vertebrae compression and Colles' fractures). Osteoporosis is a multi-factorial disease with potential contributions from genetic, endocrine functional, exercise related and nutritional factors. Of particular considerations are calcium (Ca) status, vitamin D, fluoride, magnesium and other trace elements. Several trace elements such as zinc and copper are essential for normal development of the skeleton in humans and animals. Fluoride accumulates in new bone and results in a net gain in bone mass, but may be associated with a tissue of poor quality. Aluminum induces impairment of bone formation. Gallium and cadmium suppresses bone turnover. However, exact involvements of the trace elements in osteoporosis have not yet been fully clarified. Numerous investigators have evaluated the role of medications and supplementations with minerals and trace substances to reverse the progression of this disease. Although bisphosphonates are still the drugs of choice, low-dosed fluoride and strontium salts have shown promise for the future. (C) 2012 Elsevier GmbH. All rights reserved.
引用
收藏
页码:149 / 152
页数:4
相关论文
共 45 条
  • [1] CROSS-CULTURAL ASSOCIATION BETWEEN DIETARY ANIMAL PROTEIN AND HIP FRACTURE - A HYPOTHESIS
    ABELOW, BJ
    HOLFORD, TR
    INSOGNA, KL
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (01) : 14 - 18
  • [2] Analysis of Three Functional Polymorphisms in Relation to Osteoporosis Phenotypes: Replication in a Spanish Cohort
    Agueda, Lidia
    Urreizti, Roser
    Bustamante, Mariona
    Jurado, Susana
    Garcia-Giralt, Natalia
    Diez-Perez, Adolfo
    Nogues, Xavier
    Mellibovsky, Leonardo
    Grinberg, Daniel
    Balcells, Susana
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2010, 87 (01) : 14 - 24
  • [3] Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: A randomized study
    Alexandersen, P
    Riis, BJ
    Christiansen, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) : 3013 - 3020
  • [4] ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1
  • [5] BOIVIN G, 1988, J BONE MINER RES, V3, P497
  • [6] Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis)
    Buehler, J
    Chappuis, P
    Saffar, JL
    Tsouderos, Y
    Vignery, A
    [J]. BONE, 2001, 29 (02) : 176 - 179
  • [7] VITAMIN-D(3) AND CALCIUM TO PREVENT HIP-FRACTURES IN ELDERLY WOMEN
    CHAPUY, MC
    ARLOT, ME
    DUBOEUF, F
    BRUN, J
    CROUZET, B
    ARNAUD, S
    DELMAS, PD
    MEUNIER, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (23) : 1637 - 1642
  • [8] FLUORIDE INCREASES RAT OSTEOBLAST FUNCTION AND POPULATION AFTER IN-VIVO ADMINISTRATION BUT NOT AFTER IN-VITRO EXPOSURE
    CHAVASSIEUX, P
    BOIVIN, G
    SERRE, CM
    MEUNIER, PJ
    [J]. BONE, 1993, 14 (05) : 721 - 725
  • [9] WEIGHT-BEARING EXERCISE TRAINING AND LUMBAR BONE-MINERAL CONTENT IN POSTMENOPAUSAL WOMEN
    DALSKY, GP
    STOCKE, KS
    EHSANI, AA
    SLATOPOLSKY, E
    LEE, WC
    BIRGE, SJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (06) : 824 - 828
  • [10] Spotlight on Strontium Ranelate In Postmenopausal Osteoporosis
    Deeks, Emma D.
    Dhillon, Sohita
    [J]. DRUGS & AGING, 2010, 27 (09) : 771 - 773